GovChime
IDVOther than small business

IDC (single-award IDV) 36E79721D0007ASTRAZENECA PHARMACEUTICALS LP

Overview

Award facts

Orders under this IDV
No orders recorded under this IDV.
Period of performance
From Feb 15, 2021
Modifications
17
Latest action Jan 20, 2026
Contract type
IDC (single-award IDV)
PIID 36E79721D0007

Description of requirement

2 LINE ITEMS FOR ANTI-INTERLEUKIN MONOCLONAL ANTIBODIES FOR ASTHMA (BENRALIZUMAB). AWARDED FOR A BASE YEAR OF 2/15/2021 TO 2/14/2022 PLUS FOUR ONE-YEAR OPTION PERIODS.

Dates and value

Award date
Signed on Jan 19, 2021
Ordering period ends
Feb 14, 2026
Ceiling
Ceiling (single-award vehicle): $377,812,500

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jan 20, 2026. View on USAspending · Recipient on SAM.gov

Recipient

NameASTRAZENECA PHARMACEUTICALS LP
LocationWILMINGTON, DE
UEIE5K2ZJ8CTJH4
CAGE code36WK2
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyASTRAZENECA PLC

Business types and certifications

For-profit organizationCorporation (not tax-exempt)Manufacturer of goods

Self-reported at the time of the action.

Agency and place

Awarding and funding

Awarded by
  1. Department of Veterans Affairs
  2. NAC PHARMACEUTICALS (36E797)
Funded by
  1. Department of Veterans Affairs
  2. NAC PHARMACEUTICALS (36E797)

Classification and competition

Classification

NAICS
325412PHARMACEUTICAL PREPARATION MANUFACTURING
Product or service (PSC)
6505DRUGS AND BIOLOGICALS (product)

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Firm fixed priceJ
Offers received
3

Solicitation and notices

Solicitation ID
36E79720R0068
Solicitation date
Oct 21, 2020
Notices

Contract details

Subcontracting plan
Commercial subcontract planG
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Commercial procedures
Commercial products/servicesA
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No

Transaction history

Modification history

Base award
Jan 19, 2021
Latest action
Jan 20, 2026 — Supplemental agreement (within scope)Modification P00017
Latest substantive action
Jan 20, 2026 — Supplemental agreement (within scope)Modification P00017
Actions by type
  • Base award1
  • Supplemental agreement (within scope)6
  • Subcontracting plan added5
  • Option exercised4
  • Other administrative action2
18 actions recorded, Jan 19, 2021 to Jan 20, 2026; each action counted once.

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Socio-economic and policy

Recovered materials and sustainability
No clauses included and no sustainability includedC
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA

Structure

Award or IDV
IDV
IDV type
IDCB
Indefinite-delivery contract type
Indefinite delivery / requirementsA
Multiple or single award
Single awardS
Awarding agency code
3600
Awarding sub-tier code
3600
Contracting office code
36E797
Transactions recorded under this award key
18

Funding

Funding agency code
3600
Funding sub-tier code
3600
Funding office code
36E797